Neuromodulation Market Poised for Robust Growth on Rising Neurological Disorders and Innovations in Therapies
-
Global neuromodulation market projected to reach $14.8 billion by 2030 due to rising neurological disorders and greater adoption of neuromodulation therapies.
-
Internal neuromodulation segment and deep brain stimulation applications dominated the market in 2022.
-
North America accounted for 36.9% revenue share in 2022; Asia Pacific expected to see maximum growth.
-
Key players include Boston Scientific, Abbott Laboratories, Medtronic, Nevro Corp, LivaNova.
-
Recent developments Approvals for new miniature neurostimulation implants, spinal cord stimulators, DAXIFY for frown lines treatment.